We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

ADVANCED INSTRUMENTS

Advanced Instruments designs, manufactures and markets laboratory products for the clinical, food and dairy, microbio... read more Featured Products: More products

Download Mobile App





Advanced Instruments Introduces New Automated Osmometer at AACC 2022

By LabMedica International staff writers
Posted on 27 Jul 2022

A new osmometer delivers the automation and data management capabilities modern clinical labs require to free up tech time, improve result turnaround times, reduce errors, and ensure effortless compliance. More...

Advanced Instruments, LLC (Norwood, MA, USA) announced the newest addition to its clinical line of freezing point osmometers, the OsmoPRO MAX Automated Osmometer, at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo. The OsmoPRO MAX has been designed for clinical laboratories of all sizes seeking higher productivity through automation. The instrument's innovative flow-through technology eliminates manual pipetting and consumables, allowing testing to begin with the push of a button.

The OsmoPRO MAX goes beyond providing accurate and precise test results to deliver a fully automated solution. It uses the industry-preferred freezing point depression method to provide reliable results in minutes. The instrument provides increased efficiency and a simplified osmolality testing workflow:

  • Direct sampling from primary tubes eliminates the need for sample cups.
  • Continuous loading of samples in their primary tubes as they arrive minimizes workflow interruptions and eliminates batch testing.
  • Ready-to-use system fluid automates cleaning between samples for up to 500 tests.
  • Automated barcode scanning reduces transcription errors and prevents sample mix-ups.
  • Automatic data upload capability to the AdvancedQC peer group program facilitates monitoring of quality control trends and instrument performance.

"The OsmoPRO MAX delivers the ease of use, automation, and data management features today's clinical laboratories seek," said Byron Selman, CEO of Advanced Instruments. "Advanced Instruments continues to innovate in the field of osmometry while remaining committed to the product quality and reliability that our customers have depended on for the past 65 years."

Related Links:
Advanced Instruments, LLC 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.